학술논문
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer
Document Type
Article
Author
Waks, A.G.; Cohen, O.; Kochupurakkal, B.; Kim, D.; Dunn, C.E.; Buendia Buendia, J.; Wander, S.; Helvie, K.; Lloyd, M.R.; Marini, L.; Hughes, M.E.; Freeman, S.S.; Ivy, S.P.; Geradts, J.; Isakoff, S.; LoRusso, P.; Adalsteinsson, V.A.; Tolaney, S.M.; Matulonis, U.; Krop, I.E.; D’Andrea, A.D.; Winer, E.P.; Lin, N.U.; Shapiro, G.I.; Wagle, N.
Source
In Annals of Oncology May 2020 31(5):590-598
Subject
Language
ISSN
0923-7534